With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

No significant news for NVS in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...

Oct 16 (Reuters) - Novartis (NOVN.S), opens new tab has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S. market by blocking regulators from ...

The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...

Swiss pharmaceutical giant Novartis raised its 2024 financial targets Tuesday after posting rising sales and margins in the third quarter, thanks in part to increased production of a prostate ...

Novartis has said it plans to submit the new data to regulators and present the data in full at a future medical congress. Leqvio was first approved in 2021 as an add-on to statin therapy in ...

Industry bodies representing Australian nuclear medicine clinicians and medical imaging practices said in a joint statement that Novartis had threatened specialists with legal action if they ...

Novartis is paying Chengdu Baiyu Pharmaceutical $70 million to add to its crop of cancer candidates. The deal, which features $1.1 billion in milestones, covers the global rights to a small ...

Novartis NVS announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (EMA) recommended granting approval to the breast cancer drug Kisqali ...

(You can read the full research report on Cisco here >>>) BK Technologies’ shares have outperformed the Zack Wireless Equipment industry over the ... Kisqali, Pluvicto Drive Novartis (NVS) Amid ...

Learn about Novartis India Ltd in Chennai, Tamil Nadu.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...